Alphagan and Isosorbide dinitrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan (brimonidine tartrate) and Isosorbide dinitrate (isosorbide dinitrate). Common drug interactions include flushing among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan and Isosorbide dinitrate. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.



On Aug, 02, 2026

29 people who take Alphagan and Isosorbide dinitrate together, and have interactions are studied.

Alphagan and Isosorbide dinitrate drug interactions.

What are the common drug interactions of Alphagan and Isosorbide Dinitrate, by gender? *:

female:

  1. Flushing (the warm, red condition of human skin)
  2. Headache (pain in head)
  3. Hemiparesis (weakness on one side of the body)
  4. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  5. Hypotension (abnormally low blood pressure)
  6. Intraocular pressure increased
  7. Muscle spasms (muscle contraction)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Optic nerve injury
  10. Oropharyngeal discomfort (pain or irritation of oropharynx)

male:

  1. Cardiac failure congestive
  2. Renal failure chronic (long lasting kidney dysfunction)
  3. Haemoglobin decreased
  4. Leukocytosis (increased white blood cells)
  5. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  6. Nasal discomfort
  7. Pruritus (severe itching of the skin)
  8. Sinusitis (inflammation of sinus)
  9. Confusional state
  10. Eczema asteatotic (severe dry skin- during the winter months and in the elderly)

What are the common drug interactions of Alphagan and Isosorbide Dinitrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abasia (inability to walk)
  2. Antinuclear antibody positive
  3. Balance disorder
  4. Blindness
  5. Blood creatinine increased
  6. Blood urea increased
  7. Blood uric acid increased
  8. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  9. Dizziness
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Cardiac failure congestive
  2. Renal failure chronic (long lasting kidney dysfunction)
  3. Erythema (redness of the skin)
  4. Oedema peripheral (superficial swelling)
  5. Osteomyelitis (infection of bone)
  6. Pleural effusion (water on the lungs)
  7. Pruritus (severe itching of the skin)
  8. Abdominal distension
  9. Abdominal pain lower
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Pain: 3 people, 10.34%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 10.34%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.34%
  4. High Blood Pressure: 3 people, 10.34%
  5. Chest Pain: 3 people, 10.34%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.34%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.90%
  8. Essential Thrombocythaemia (chronic blood cancer): 2 people, 6.90%
  9. Diabetes: 2 people, 6.90%
  10. Depression: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan and Isosorbide dinitrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alphagan and Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alphagan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alphagan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate and isosorbide dinitrate (the active ingredients of Alphagan and Isosorbide dinitrate, respectively), and Alphagan and Isosorbide dinitrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: